The present disclosure relates to structures, functions, and fabrication methods for a biosensor, and more particularly a test strip used for analyte detection.
Blood glucose measurement systems typically comprise an analyte meter that is configured to receive a biosensor, usually in the form of an analytical test strip. A user may obtain a small sample of blood typically by a fingertip skin prick and then may apply the sample to the test strip to begin a blood analyte assay. Because many of these measurement systems are portable, and testing can be completed in a short amount of time, patients are able to use such devices in the normal course of their daily lives without significant interruption to their personal routines. A person with diabetes may measure their blood glucose levels several times a day as a part of a self management process to ensure glycemic control of their blood glucose within a target range. A failure to maintain target glycemic control can result in serious diabetes-related complications including cardiovascular disease, kidney disease, nerve damage and blindness.
Analyte detection assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions. Analytes of interest include glucose for diabetes management, cholesterol, and the like. In response to this growing importance of analyte detection, a variety of analyte detection protocols and devices for both clinical and home use have been developed.
One type of method that is employed for analyte detection is an electrochemical method. In such methods, a bodily fluid sample is placed into a sample-receiving chamber in an electrochemical cell that includes two electrodes, e.g., a counter and working electrode. The analyte is allowed to react with a redox reagent to form an oxidizable (or reducible) substance in an amount corresponding to the analyte concentration. The quantity of the oxidizable (or reducible) substance present is then estimated electrochemically and related to the amount of analyte present in the initial sample.
The electrochemical cell is typically present on a test strip which is configured to electrically connect the cell to an analyte measurement device. While current test strips are effective, the size of the test strips can directly impact the manufacturing costs. While it is desirable to provide test strips having a size that facilitates handling of the strip, increases in size will tend to increase manufacturing costs where there is an increased amount of material used to form the strip. Moreover, increasing the size of the test strip tends to decrease the quantity of strips produced per batch, thereby further increasing manufacturing costs. Accordingly, there is a need for improved electrochemical sensing apparatus and methods.
These and other embodiments, features and advantages will become apparent to those skilled in the art when taken with reference to the following more detailed description of various exemplary embodiments of the invention in conjunction with the accompanying drawings that are first briefly described.
The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain features of the invention (wherein like numerals represent like elements).
Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the present disclosure is defined solely by the claims. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present disclosure.
As used herein, the terms “patient” or “user” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.
The term “sample” means a volume of a liquid, solution or suspension, intended to be subjected to qualitative or quantitative determination of any of its properties, such as the presence or absence of a component, the concentration of a component, e.g., an analyte, etc. The embodiments of the present invention are applicable to human and animal samples of whole blood. Typical samples in the context of the present invention as described herein include blood, plasma, red blood cells, serum and suspensions thereof.
The term “about” as used in connection with a numerical value throughout the description and claims denotes an interval of accuracy, familiar and acceptable to a person skilled in the art. The interval governing this term is preferably ±10%. Unless specified, the terms described above are not intended to narrow the scope of the invention as described herein and according to the claims. The terms “top” and “base” as used herein are intended to serve as a reference for illustration purposes only, and that the actual position of the portions of the test strip will depend on its orientation.
The present invention generally provides a biosensor, such as an analytical test strip having disposed electrodes that are configured to communicate with an analyte measurement system, and more particularly a portable test meter. The test strip design is particularly advantageous in that the design is compact, while providing a large effective surface area for ease of handling. The smaller size of the electrochemical biosensor may reduce manufacturing costs, as less material is required to manufacture it.
The biosensor 100 can have various configurations, but is typically in the form of one or more rigid or semi-rigid layers having sufficient structural integrity to allow handling and connection to an analyte measurement system, as will be discussed in further detail below. The biosensor 100 may be formed from various materials, including plastic and other insulating materials. The material of the various layers, other than the reagent layer 107, typically is one that is insulating (non-conductive) and may be inert and/or electrochemically non-functional, where they do not readily corrode over time nor chemically react with a sample applied to the biosensor 100. The top electrode 100 includes a conductive material, or layer, 102 disposed on the bottom surface thereof (facing the base electrode 109). The base electrode 109 also includes a conductive material, or layer, 110 disposed on the upper surface thereof (facing the top electrode 101). The conductive layers 102, 110 should be resistant to corrosion wherein their conductivity does not change during storage of the biosensor 100.
In the assembled embodiment shown in
The top and base electrodes 101, 109 include a substantially insulating and inert substrate, 106, 108, respectively, and have a conductive material disposed on one surface thereof 102, 110, respectively, to facilitate communication between electrodes of the electrochemical biosensor and an analyte measurement system or device. The electrically conducting layers 102, 110 can be formed from any conductive material, including inexpensive materials, such as aluminum, carbon, graphene, graphite, silver ink, tin oxide, indium oxide, copper, nickel, chromium and alloys thereof, and combinations thereof. However, precious metals that are conductive, such as palladium, platinum, indium tin oxide or gold, can optionally be used. The electrically conducting layers may be disposed on the entire inward facing surfaces of the top and base electrodes 101, 109, or they may terminate at a distance (e.g., 1 mm) from the edges of the electrodes 101, 109 but the particular locations of the electrically conducting layers should be configured to electrically couple the electrochemical biosensor to an analyte measurement system or device. In one exemplary embodiment, the entire portion or a substantial portion of the inwardly facing surfaces of the top and base electrodes 101, 109 are coated with the electrically conducting layers 102, 110 at a preselected thickness. As a result, each of the top and base electrodes 101, 109 includes an electrically conducting coating disposed thereon. Thus, when the electrochemical biosensor is assembled, as shown in
To maintain electrical separation between the top and base conductive layers 102, 110, the biosensor 100 may further include a spacer layer, comprising proximal and distal spacers 104, 105, which may also be adhesive spacers for securing the top and base electrodes 101, 109, in a spaced relationship. The spacers 104, 105 can function to maintain the top and base electrodes 101, 109 at a distance apart from one another, thereby preventing electrical contact between the co-facial top and bottom electrically conducting layers 102, 110. The spacer layer may include double-sided adhesive spacers 104, 105 to adhere the top and base electrodes 101, 109 to one another. The spacers 104, 105 may be formed from a variety of materials, including a material with adhesive properties, or the spacers 104, 105 can include a separate adhesive used to attach the spacers 104, 105 to the electrodes 101, 109. Non-limiting examples of ways in which adhesives can be incorporated into the various biosensor assemblies of the present disclosure can be found in U.S. Pat. No. 8,221,994 of Chatelier et al., entitled “Adhesive Compositions for Use in an Immunosensor”, the contents of which is incorporated by reference as if fully set forth herein in its entirety.
The spacers 104, 105 may have various shapes and sizes and can be positioned in various positions between the top and base electrodes 101, 109. In the embodiment shown in
As best shown in
The configuration of the electrical contact pads 103, 111 allows an analyte measurement system or device to electrically contact the electrodes 101, 109. The biosensor 100 can be configured to couple to a variety of analyte measurement systems and devices as explained below.
In one embodiment, the biosensor 100 may include top and base electrodes 101, 109 and a reagent film, or layer, 107 on the electrically conductive layer 110 of the base electrode between the spacers 104, 105. The reagent layer 107 reacts with an analyte in a fluid sample provided in the sample chamber 113 by a user of the biosensor. The top and base electrodes may be configured in any suitable configuration in an opposed spaced apart relationship for receiving a sample. The illustrated reagent film 107 may be disposed on either of the top or base electrodes 101, 109 and between the spacers 104, 105 and within the chamber 113 for coming into contact, and reacting, with an analyte in an applied sample. A person skilled in the art will appreciate that the electrochemical biosensor 100 may have a variety of configurations, including having other electrode configurations, such as co-planar electrodes.
In the illustrated embodiment, the spacers 104, 105 each have a generally square or rectangular shape. The spacers 104, 105 may be formed from various materials, but in an exemplary embodiment they are formed from a material having a small coefficient of thermal expansion such that the spacers do not adversely affect the volume of the sample chamber 113. As shown in
When the electrochemical biosensor 100 is assembled, the top and base electrodes may be held together at a spaced distance apart by one or more of the spacers 104, 105 which have a generally rectangular configuration with a width that can be substantially equal to a width We (
As shown in
As indicated above, the spacers 104, 105 and the electrodes 101, 109 generally define a space or gap, also referred to as a window, therebetween which forms an electrochemical cavity or sample chamber 113 for receiving a sample. In particular, the top and base electrodes 101, 109 define the top and bottom of the sample chamber 113 and the spacers 104, 105 define the sides of the sample chamber 113. The gap between the spacers 104, 105 will result in an opening or inlet extending into the sample chamber 113. The sample can thus be loaded through the opening or inlet. In one exemplary embodiment, the volume of the sample chamber can range from about 0.1 microliters to about 5 microliters, preferably about 0.2 microliters to about 3 microliters, and more preferably about 0.2 microliters to about 0.4 microliter. To provide the small volume, the gap between the spacers 104, 105 have an area ranging from about 0.005 cm2 to about 0.2 cm2, preferably about 0.0075 cm2 to about 0.15 cm2, and more preferably about 0.01 cm2 to about 0.08 cm2, and the thickness of the spacers 104, 105 can range from about 1 micron to 500 microns, and more preferably about 10 microns to 400 microns, and more preferably about 40 microns to 200 microns, and even more preferably about 50 microns to 150 microns. As will be appreciated by those skilled in the art, the volume of the sample chamber 113, the area of the gap between the spacers 104, 105, and the distance between the electrodes 101, 109 can vary significantly.
As further illustrated, the sample chamber 113 may also include a reagent film or layer 107 disposed on at least one of the electrodes, e.g., the base electrode 109 as illustrated. Alternatively, the reagent layer can be disposed on multiple faces of the sample chamber 113. The reagent layer 107 can be formed from various materials, including various mediators and/or enzymes. Suitable mediators include, by way of non-limiting example, ferricyanide, ferrocene, ferrocene derivatives, osmium bipyridyl complexes, and quinone derivatives. Suitable enzymes include, by way of non-limiting example, glucose oxidase, glucose dehydrogenase (GDH) based onpyrroloquinoline quinone (PQQ) co-factor, GDH based on nicotinamide adenine dinucleotide co-factor, and FAD-based GDH. One exemplary reagent formulation, which would be suitable for making the reagent layer 107, is described in U.S. Pat. No. 7,291,256, entitled “Method of Manufacturing a Sterilized and Calibrated Biosensor-Based Medical Device,” the entirety of which is hereby incorporated as if fully set forth herein by reference. The reagent layer 107 can be formed using various processes, such as slot coating, dispensing from the end of a tube, ink jetting, and screen printing. While not discussed in detail, a person skilled in the art will also appreciate that the various electrochemical modules disclosed herein can also contain a buffer, a wetting agent, and/or a stabilizer for the biochemical component.
With reference to
With reference to
The laminating step forms a trilaminate structure as seen in
It should be noted that the fabrication steps just described may be modified in various combinations as is well known to those skilled in the art. For example, the base electrode material may be used to form the wider, castellated web, and a non-castellated web used to form the top electrode, effectively reversing the exposed contact points within the system. The reagent layer may be applied, as necessary, to the top electrode conducting layer in that instance. The fabrication steps just described may be appropriately sequenced in various combinations and is considered to be within the scope of the present disclosure. One advantage of this approach is that it makes use of an interlocking sensor web design that, when cut, forms two continuous sensor webs without wasting fabrication materials. This may be achieved by ensuring that the biosensor reagent strip is centrally placed on the web, so that when the two sensor webs are singulated by cutting, then two identical functioning webs of sensors are created.
With reference to
The shape of the carrier 301, 302 can also vary. In the embodiments shown in
The carrier 301, 302 also includes windows 309 to provide access and to facilitate communication between contact pads 103, 111 of the biosensor 100 and an analyte measurement system or device when the test strip 300, 305 is inserted therein. The quantity of edge cut openings 307 and the location of each opening 307 can vary depending on the intended use, for example, whether more than one biosensor 100 will be present in a carrier 301, 302. In the illustrated embodiments, the opening 307 is positioned along a perimeter of the carrier 301, 302. While not shown, the opening 307 can alternatively be positioned along any edge of the carrier 301, 302. The interior surfaces of the first and second layers of the carrier 301, 302 may include an adhesive to secure the biosensor therewithin.
While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well.